WFA of San Diego’s Integra LifeSciences IART Stock Holding History

WFA of San Diego’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8	Closed	–	–	208
2022 Q2	$0	Buy	+8	New	+$480	﹤0.01%	415

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

WFA of San Diego's IART Position: Q3 2022 in Review

WFA of San Diego sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 8 shares.

WFA of San Diego first reported a position in IART in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

WFA of San Diego reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
WFA of San Diego sold 8 Integra LifeSciences shares in Q3 2022.
WFA of San Diego first reported a position in Integra LifeSciences in Q2 2022 and held it in 1 quarter.
WFA of San Diego's Integra LifeSciences position peaked at $0 in Q2 2022.
282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on WFA of San Diego's 13F filing for Q3 2022, filed 18 Oct 2022.